date:May 10, 2012
The ingredient dubbed NM504 is now entering a human clinical trial in a powdered drink mix, Dr Dean Stull, chief executive at New Orleans-based biotech NuMe Health told NutraIngredients-USA.
Weve filed a patent application for NM504, which contains a combination of three GRAS (generally recognized as safe) ingredients. They are a standard prebiotic ingredient, an oat-based ingredient and a berry-based concentrate.
The patent is a composition patent covering the specific ratio of the ingred